253 related articles for article (PubMed ID: 19159496)
1. Clinical implications of ovarian reserve testing.
Steiner AZ
Obstet Gynecol Surv; 2009 Feb; 64(2):120-8. PubMed ID: 19159496
[TBL] [Abstract][Full Text] [Related]
2. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age.
Riggs RM; Duran EH; Baker MW; Kimble TD; Hobeika E; Yin L; Matos-Bodden L; Leader B; Stadtmauer L
Am J Obstet Gynecol; 2008 Aug; 199(2):202.e1-8. PubMed ID: 18674663
[TBL] [Abstract][Full Text] [Related]
3. Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus.
Soto N; Iñiguez G; López P; Larenas G; Mujica V; Rey RA; Codner E
Hum Reprod; 2009 Nov; 24(11):2838-44. PubMed ID: 19643804
[TBL] [Abstract][Full Text] [Related]
4. A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles.
Robertson DM; Hale GE; Fraser IS; Hughes CL; Burger HG
Menopause; 2008; 15(6):1139-44. PubMed ID: 18779761
[TBL] [Abstract][Full Text] [Related]
5. Heterozygosity for the classical galactosemia mutation does not affect ovarian reserve and menopausal age.
Knauff EA; Richardus R; Eijkemans MJ; Broekmans FJ; de Jong FJ; Fauser BC; Bosch AM
Reprod Sci; 2007 Dec; 14(8):780-5. PubMed ID: 18089596
[TBL] [Abstract][Full Text] [Related]
6. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project.
Burger HG; Hale GE; Robertson DM; Dennerstein L
Hum Reprod Update; 2007; 13(6):559-65. PubMed ID: 17630397
[TBL] [Abstract][Full Text] [Related]
7. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study.
van Rooij IA; Broekmans FJ; Scheffer GJ; Looman CW; Habbema JD; de Jong FH; Fauser BJ; Themmen AP; te Velde ER
Fertil Steril; 2005 Apr; 83(4):979-87. PubMed ID: 15820810
[TBL] [Abstract][Full Text] [Related]
8. Possibilities and limits of ovarian reserve testing in ART.
La Marca A; Argento C; Sighinolfi G; Grisendi V; Carbone M; D'Ippolito G; Artenisio AC; Stabile G; Volpe A
Curr Pharm Biotechnol; 2012 Mar; 13(3):398-408. PubMed ID: 21657996
[TBL] [Abstract][Full Text] [Related]
9. Inhibin A and B as markers of menopause: a five-year prospective longitudinal study of hormonal changes during the menopausal transition.
Overlie I; Mørkrid L; Andersson AM; Skakkebaek NE; Moen MH; Holte A
Acta Obstet Gynecol Scand; 2005 Mar; 84(3):281-5. PubMed ID: 15715537
[TBL] [Abstract][Full Text] [Related]
10. Relevance of anti-Mullerian hormone measurement in a routine IVF program.
Gnoth C; Schuring AN; Friol K; Tigges J; Mallmann P; Godehardt E
Hum Reprod; 2008 Jun; 23(6):1359-65. PubMed ID: 18387961
[TBL] [Abstract][Full Text] [Related]
11. Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age.
Steiner AZ; Pritchard D; Stanczyk FZ; Kesner JS; Meadows JW; Herring AH; Baird DD
JAMA; 2017 Oct; 318(14):1367-1376. PubMed ID: 29049585
[TBL] [Abstract][Full Text] [Related]
12. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
[TBL] [Abstract][Full Text] [Related]
13. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
14. Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction.
Al-Azemi M; Killick SR; Duffy S; Pye C; Refaat B; Hill N; Ledger W
Hum Reprod; 2011 Feb; 26(2):414-22. PubMed ID: 21147822
[TBL] [Abstract][Full Text] [Related]
15. Measuring ovarian function in young cancer survivors.
Su HI
Minerva Endocrinol; 2010 Dec; 35(4):259-70. PubMed ID: 21178920
[TBL] [Abstract][Full Text] [Related]
16. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition.
Sowers MR; Eyvazzadeh AD; McConnell D; Yosef M; Jannausch ML; Zhang D; Harlow S; Randolph JF
J Clin Endocrinol Metab; 2008 Sep; 93(9):3478-83. PubMed ID: 18593767
[TBL] [Abstract][Full Text] [Related]
17. Detection of serum antimüllerian hormone in women approaching menopause using sensitive antimüllerian hormone enzyme-linked immunosorbent assays.
Robertson DM; Kumar A; Kalra B; Shah S; Pruysers E; Vanden Brink H; Chizen D; Visser JA; Themmen AP; Baerwald A
Menopause; 2014 Dec; 21(12):1277-86. PubMed ID: 24781853
[TBL] [Abstract][Full Text] [Related]
18. Inhibins and adult ovarian function.
Laven JS; Fauser BC
Mol Cell Endocrinol; 2004 Oct; 225(1-2):37-44. PubMed ID: 15451566
[TBL] [Abstract][Full Text] [Related]
19. [Measurement of serum AMH levels in gynecology: indications and limits].
Streuli I; Cantero-Perez P; Miserez-Zaugg C
Rev Med Suisse; 2013 Oct; 9(403):1954-6, 1958. PubMed ID: 24245018
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine changes in the aging reproductive axis of female rhesus macaques (Macaca mulatta).
Downs JL; Urbanski HF
Biol Reprod; 2006 Oct; 75(4):539-46. PubMed ID: 16837643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
